Sodium Nitrite Injection

MARCH 01, 2004

Hope Pharmaceuticals (Scottsdale, Ariz) recently announced the release of Sodium Nitrite Injection USP 3% in singledose vials. This product is indicated for the treatment of cyanide poisoning. It is a primary component of the Cyanide Antidote Kit, which is used by hospitals and public safety authorities for emergency preparedness. Cyanide inhalation can cause severe toxic effects and death within minutes to hours. Prompt treatment is critical for patient survival. The new vials facilitate rapid administration during an emergency. For more information, visit www.hopepharm.com.



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.